Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Grant or award Director acquired 37,153 shares (grant or award)
  2. 4 Grant or award Director acquired 37,153 shares (grant or award)
  3. 4 Planned sale Director sold 20,000 shares at $7.85 ($157,000)
  4. 4 Open-market sale Chief Financial Officer & PAO sold 14,384 shares at $7.12 ($102,414)
  5. 4 Open-market sale PRESIDENT AND CEO sold 27,689 shares at $7.14 ($197,699)
  6. 4 Planned sale GENERAL COUNSEL sold 22,355 shares at an average $7.65 ($170,921)
  7. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 5,779 shares at an average $7.13 ($41,193)
  8. 4 Planned sale Director sold 55,453 shares at an average $8.28 ($459,086)
  9. 4 Planned sale Director sold 4,547 shares at an average $6.52 ($29,625)
  10. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 4,376 shares at an average $6.18 ($27,065)
  11. 4 Open-market sale GENERAL COUNSEL sold 5,497 shares at an average $6.19 ($34,006)
  12. 4 Planned sale Director sold 20,000 shares at $6.63 ($132,600)
  13. 4 Planned sale Director sold 20,000 shares at $6.52 ($130,400)
  14. 4 Planned sale Director sold 20,000 shares at $8.09 ($161,800)
  15. 4 Open-market sale CHIEF COMMERCIAL OFFICER sold 4,586 shares at an average $6.70 ($30,721)
  16. 4 Open-market sale GENERAL COUNSEL sold 5,765 shares at an average $6.69 ($38,576)
  17. 4 Open-market buy PRESIDENT AND CEO bought 14,245 shares at $6.84 ($97,436)
  18. 4 Planned sale CHIEF COMMERCIAL OFFICER sold 1,184 shares at $6.16 ($7,293)
  19. 4 Grant or award Director acquired 15,216 shares (grant or award)
  20. 4 Grant or award Director acquired 15,216 shares (grant or award)

Page 3 of 12 · 229 filings